Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy

(2012) Jason R. Andrews et al.   AIDS

Rapid Implementation of New TB Diagnostic Tests: Is It Too Soon for a Global Roll-Out of Xpert MTB/RIF?

(2012) Daniela E. Kirwan et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Rapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens

(2012) H. J. Zar et al.   CLINICAL INFECTIOUS DISEASES

Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study

(2012) Andrea Rachow et al.   CLINICAL INFECTIOUS DISEASES

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]

(2012) A. Van Rie et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

(2012) Gesine Meyer-Rath et al.   PLoS One

Scaling up Xpert MTB/RIF technology: the costs of laboratory-vs.clinic-based roll-out in South Africa

(2012) Kathryn Schnippel et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The cost of providing comprehensive HIV treatment in PEPFAR-supported programs

(2011) Nicolas A. Menzies et al.   AIDS

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

(2011) Grant Theron et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Côte d’Ivoire

(2011) Xavier Anglaret et al.   CLINICAL INFECTIOUS DISEASES

Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities

(2011) L. M. Parsons et al.   CLINICAL MICROBIOLOGY REVIEWS

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

(2011) Grant Theron et al.   EUROPEAN RESPIRATORY JOURNAL

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

(2011) A. Trébucq et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

(2011) Catharina C Boehme et al.   LANCET

Point-of-care tuberculosis diagnosis: are we there yet?

(2011) Claudia M Denkinger et al.   LANCET INFECTIOUS DISEASES

Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study

(2011) Andrea Rachow et al.   PLoS One

GeneXpert—A Game-Changer for Tuberculosis Control?

(2011) Carlton A. Evans   PLOS MEDICINE

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

(2011) Stephen D. Lawn et al.   PLOS MEDICINE

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

(2011) David W. Dowdy et al.   PLOS MEDICINE

Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

(2011) Lesley E. Scott et al.   PLOS MEDICINE

Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis

(2011) Anna Vassall et al.   PLOS MEDICINE

Costs and Consequences of Additional Chest X-Ray in a Tuberculosis Prevention Program in Botswana

(2010) Taraz Samandari et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study

(2010) Weerawat Manosuthi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

(2010) Catharina C. Boehme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral therapy for tuberculosis control in nine African countries

(2010) B. G. Williams et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009

(2010) T. Brown et al.   SEXUALLY TRANSMITTED INFECTIONS

Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities

(2010) John H. Bratt et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Determinants of knowledge of HIV status in South Africa: results from a population-based HIV survey

(2009) Karl Peltzer et al.   BMC PUBLIC HEALTH

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

(2009) David Dowdy   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Rapid Detection ofMycobacterium tuberculosisand Rifampin Resistance by Use of On-Demand, Near-Patient Technology

(2009) Danica Helb et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

(2009)   LANCET

Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study

(2008) Graeme Meintjes et al.   BMC INFECTIOUS DISEASES

Cost‐Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug‐Resistant Tuberculosis in Middle‐Income Countries

(2008) Carlos Acuna‐Villaorduna et al.   CLINICAL INFECTIOUS DISEASES

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

(2008) Reuben M Granich et al.   LANCET

Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical Assessment

(2008) Ziad Obermeyer et al.   PLoS One

Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing

(2008) D. W. Dowdy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bayesian melding for estimating uncertainty in national HIV prevalence estimates

(2008) L Alkema et al.   SEXUALLY TRANSMITTED INFECTIONS

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

(2008) Sydney Rosen et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Eliminating human tuberculosis in the twenty-first century

(2007) C. Dye et al.   Journal of the Royal Society Interface